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Bioorthogonal chemistry has recently emerged to be one of the most powerful tools in
drug discovery and chemical biology. The exploration of it has successfully advanced the
field of natural product research. In this Perspective, we survey current strategies for the
installation of chemical handles into the molecular scaffolds of several major classes of
natural products, including polyketides (PKs), non-ribosomal peptides (NRPs), and their
hybrids. By tagging these natural products with chemical handles and coupling them with
subsequent bioorthogonal reactions, researchers have visualized and studied the mode of
action of natural products, as well as synthesized derivatives with better pharmaceutical
properties. We conclude this Perspective by considering two questions: is there a general
way to synthesize tagged PKs/NRPs? Does natural product labeling have a broader impact
in the field of natural product research beyond current known applications?
Keywords: natural product labeling, bioorthogonal chemistry, alkyne-azide cycloaddition, polyketides, non-
ribosomal peptides, biosynthesis
INTRODUCTION
Nature’s small molecules derived from microbes, plants, and ani-
mals have played an enormous role in the history of medicinal
and pharmaceutical chemistry. In the past two decades, more
than one third of small molecule-based drugs approved by the US
Food and Drug Administration (FDA) were natural products or
their derivatives (Newman and Cragg, 2012). Collectively, natural
products have been widely used to treat nearly all human health
conditions, including but not limited to infectious, neurological,
cardiovascular, metabolic and oncological diseases (Butler, 2008).
It has been estimated that most major classes of antibiotics and
over 70% of anti-cancer small molecule treatments are natural
products, their derivatives or mimics (Newman and Cragg, 2012).
Whereas, combinatorial chemistry fails to deliver leads that form
the basis for the development of successful new drugs, medicinally
active natural products have functional group arrays and scaffold
architectures that offer advanced platforms for the optimization
of compound activity profiles.
Although the pharmaceutical value of natural products has
been widely recognized, it is still challenging to transformmedici-
nally active natural products into drugs (Clardy andWalsh, 2004).
Firstly, sufficient quantities of natural products are required
to fully characterize their chemical and biological properties.
Considering the small amount of natural products that are
typically obtained by biological fermentation, the preparation
process can be time-consuming and labor-intensive. Secondly,
most medicinally active natural products exert inhibitory func-
tions on specific protein targets, and the identification of these
protein targets is essential for successful drug development. Since
the weak specificities and affinities between natural products
and protein targets complicate the interpretation of experimen-
tal data, fishing for the protein targets of natural products from
an entire proteome depends on the development of sensitive
and reliable methods (Carlson, 2010). Thirdly, natural product-
based new drug screening requires a library of natural products
and their derivatives. However, current approaches to generate
such library are limited, often relying on complicated chemical
syntheses (Thirumurugan et al., 2013).
An emerging enabling technology for expanding the natural
product research toolkit is tagging natural products with a unique
chemical handle that can be subjected to further bioorthogonal
chemical transformations (Figure 1). The recent development of
bioorthogonal chemistry is paving the way for new innovation in
biology; it has produced new tools for labeling macromolecules,
enabling the selective visualization and study of proteins, glycans,
nucleic acids, and lipids (Prescher and Bertozzi, 2005; Grammel
and Hang, 2013). Analogously, tagging natural products with a
unique chemical handle will enable the visualization, enrichment,
quantification, and mode of action study of natural products
through bioorthogonal chemistry. This approach would have a
profound impact on our ability to address challenging questions
in natural product biosynthesis, biology, and pharmacology.
However, despite the success with macromolecules, the labeling
of natural products has not been adequately explored with fewer
examples.
This perspective will discuss current strategies for label-
ing natural products and their applications in natural product
research (Figure 1). We will limit the scope of this perspective
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FIGURE 1 | Overview of different strategies for labeling natural products and their applications through bioorthogonal chemistry.
to the labeling of polyketides (PKs) and non-ribosomal peptides
(NRPs), which are the major classes of natural products noted for
their functional and chemical diversity. We will also limit our dis-
cussion of bioorthogonal chemical transformations to the most
widely used azide-alkyne [3+2] cycloaddition reaction, although
many strategies and applications can also be applied to other
bioorthogonal pairs (Prescher and Bertozzi, 2005; Sletten and
Bertozzi, 2009).
LABELING OF PKs/NRPs THROUGH CHEMICAL SYNTHESIS
Chemical synthesis, such as total organic synthesis or semi-
synthesis, is a well-adopted approach to install a “clickable”
functionality on molecular scaffolds of natural products. The
resulting orthogonally functionalized natural product analogs can
be further modified through facile and selective chemical trans-
formations for diversification, andmore interestingly, for applica-
tion in activity-based protein profiling experiments. For example,
Cravatt and Sorensen’s groups chemically synthesized a library
of spiroepoxides inspired by natural products such as fumagillin,
lumanicin D, and FR901464, and they performed in situ proteome
reactivity profiling to determine the protein targets (Evans et al.,
2005). Particularly, an alkyne handle was included in the scaffold
of synthetic small molecule chemical probes, and two down-
stream azide-modified reporters were used: a rhodamine-azide
reporter for initial protein target visualization by in-gel fluo-
rescence scanning, and a trifunctional rhodamine-biotin-azide
reporter for protein target enrichment, chromatographic purifi-
cation, and further mass spectrometry analysis to determine the
identity of the protein target. Similarly, Sieber’s group synthesized
alkyne-tagged β-lactams as selective chemical probes for the iden-
tification of bacterial enzymes involved in antibiotic resistance
(Staub and Sieber, 2008, 2009). These artificial lactam probes
were stable enough to resist β-lactamase hydrolysis, and were
successfully used to detect and monitor the activities of several
resistance associated proteins by fluorescence scanning and mass
spectrometry analysis. It is notable that the sterically inconspic-
uous alkyne tag allowed the introduction of the bulky reporter
group after enzyme binding and cell preparation, enabling the
click chemistry-based analysis of proteins modified by tagged
natural products in living cells. These results suggest that devel-
opment of orthogonally functionalized natural products will help
with studying the mode of action of natural products and aid
in the discovery of new drug targets for customized therapeutic
interventions. Alternatively, an azido functionality has also been
introduced into the molecular scaffolds of natural products. For
example, Sulikowski’s group installed an azido handle into apop-
tolidins through chemical esterification of apoptolidins A and
H obtained from microbial fermentation (DeGuire et al., 2015).
These azido-functionalized analogs were shown to be as potent as
their parent apoptolidins when evaluated by a cell viability assay.
In addition, the cellular localization of these azido-labeled analogs
in H292 human lung carcinoma cells were successfully visualized
and identified using an alkyne-containing fluorescent reporter.
LABELING OF PKs/NRPs THROUGH BIOSYNTHESIS
BIOSYNTHETIC LOGIC FOR PKs AND NRPs
PKs, NRPs and their hybrids are major families of natural prod-
ucts with remarkable structural diversity and medicinal potential.
These natural products are formed through the controlled assem-
bly of simple biosynthetic building blocks with diverse tailoring
reactions (Fischbach andWalsh, 2006; Hertweck, 2009). PK back-
bones are constructed by repeated condensations of acyl-CoAs
catalyzed by polyketide synthases (PKSs) containing the core cat-
alytic domains of ketosynthase (KS), acyltransferase (AT), and
acyl carrier protein (ACP); and NRPs are assembled by condensa-
tions of amino acid monomers catalyzed by non-ribosomal pep-
tide synthetases (NRPSs) containing the core catalytic domains of
adenylation (A), condensation (C) and thiolation (T) (Fischbach
andWalsh, 2006). A thorough understanding of PK/NRP biosyn-
thetic machinery, particularly the substrate promiscuity, facil-
itates the installation of clickable functionalities onto diverse
molecular scaffolds of PKs/NRPs through biosynthesis.
LABELING OF PKs/NRPs THROUGH PRECURSOR DIRECTED
BIOSYNTHESIS
Precursor directed biosynthesis (PDB) has been widely used to
tag biomolecules, such as proteins, glycans, and nucleic acids,
based on their promiscuous biosynthetic machinery (Grammel
andHang, 2013). Analogously, this approach represents a promis-
ing alternative to chemical synthesis for introducing a unique tag
into natural product backbones with the incorporation of unnat-
ural precursors. Depending on the relaxed substrate specificity
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of PKS and NRPS machinery, precursors with a bioorthogo-
nal handle can be incorporated at the loading, extending, or
tailoring stage of the biosynthetic pathways. Most downstream
biosynthetic enzymes are expected to tolerate tagged biosyn-
thetic intermediates, yielding predictable labeled natural products
(Harvey and Khosla, 2012).
Based on the relaxed substrate specificity of the PKS at the
loading stage, Khosla’s group utilized the PDB approach to
make an orthogonally functionalized erythromycin analog: 15-
propargyl erythromycin A (Harvey et al., 2012). After they fed
a synthetic terminal alkyne-tagged precursor that mimicked the
natural diketide starter unit into the engineered biosynthetic
pathway of erythromycin in Escherichia coli, the precursor was
incorporated into the polyketide scaffold by the KS domain
from module 2 of the 6-deoxyerythronolide B synthase (DEBS).
This novel erythromycin analog showed comparable antibiotic
potency as the clinically used erythromycin A in several bioassays.
The strategy of extender unit engineering, particularly based
on a promiscuous AT domain that is native or achieved through
site-directed mutagenesis, has also led to the introduction of a
clickable functionality into PKs and PK-NRP hybrids. Although
malonyl-CoA and methylmalonyl-CoA are the most common
extender units for PKSs, atypical extender units have been found
to be incorporated into PKs and PK-NRP hybrids by natively
promiscuous AT domains. For example, it has been revealed that
the AT domain embedded in AntD from the antimycin biosyn-
thetic pathway tolerated a wide range of atypical fatty acyl exten-
der units with different chain lengths and modifications (Sandy
et al., 2012; Yan et al., 2012, 2013). Based on the relaxed substrate
specificities of AntD-AT and AntE (a reductase/decarboxylase
homolog to generate acylmalonyl-CoAs), Liu’s group biosyn-
thesized many terminal alkyne-tagged antimycin analogs after
feeding alkynoic acids into the culture of Streptomyces sp. NRRL
2288antB, an engineered antimycin producer. Alternatively, an
engineered AT domain with an altered substrate profile has also
been used for incorporating a clickable functionality. Sanchez-
Garcia and Schulz’s groups found that the single V295Amutation
of the AT domain from module 6 of DEBS enabled the incor-
poration of 2-propargylmalonyl instead of methylmalonyl as the
extender unit, yielding a new orthogonally functionalized ery-
thromycin analog: 2-propargylerythromycin in Saccharopolyspora
erythraea (Sundermann et al., 2012). This AT engineering strategy
could be possibly adopted for the engineering of other extend-
ing ATs, resulting in the site-selective introduction of a tagged
extender unit into additional PKs or PK-NRP hybrids.
Additionally, clickable functionalities can also be installed
onto the scaffolds of PKs/NRPs at the tailoring stage of the
biosynthetic pathways. For example, a promiscuous tailoring AT,
AntB from the antimycin biosynthetic pathway utilized termi-
nal alkyne-containing precursors, resulting in terminal alkyne-
labeled antimycins both in vitro and in vivo (Sandy et al., 2013;
Yan et al., 2013). One of the alkyne-functionalized antimycin
analogs was further incubated with Hela cells, followed by a
reaction with an azide-containing fluorescent reporter for visual-
ization. The efficient binding of this antimycin analog toHela cells
indicated that the installation of a terminal alkyne functionality
had no significant effect on antimycin to recognize its protein
target. In a different system, Jakeman’s group fed O-propargyl-
l-serine as the sole nitrogen source to a culture of Streptomyces
venezuelae ISP5230, and the terminal alkyne functionality was
installed onto the jadomycin scaffold non-enzymatically (Dupuis
et al., 2012). An eight-membered library of jadomycin triazoles
was further generated through subsequent reactions with a series
of azides and the anti-cancer and antibacterial activities of these
new compounds were evaluated. Using a similar approach to
generate natural product derivatives for drug screening, Walsh’s
group synthesized carbohydrate-modified cyclic peptides utiliz-
ing a promiscuous thioesterase and a facile click chemistry-based
chemical modification (Lin and Walsh, 2004). They first tar-
geted the in vitro enzymatic synthesis of terminal alkyne-tagged
cyclic tyrocidine derivatives through enzymatic macrocyclization
of synthetic linear peptideN-acetyl cysteamine (SNAC) thioesters
using the promiscuous thioesterase domain from the tyrocidine
synthetase. The subsequent conjugation to 21 azido sugars via
copper(I)-catalyzed cycloaddition yielded glycosylated cyclic pep-
tides, some of which showed an improved therapeutic index com-
pared to the natural tyrocidine. This chemoenzymatic approach
offered several advantages over purely chemical or enzymatic
synthesis. On the one hand, enzymes with relaxed substrate speci-
ficity could catalyze reactions such as macrocyclization which
were difficult to achieve through chemical synthesis; on the other
hand, chemical synthesis was more flexible than enzymatic syn-
thesis. For example, enzymatic glycosylation suffered from the
lack of promiscuous glycosyltransferases and corresponding gly-
cosyl donor substrates. The chemoenzymatic strategy thus com-
bines the strengths of both chemical and enzymatic approaches
and can be widely used for modification of other natural products
to search for new therapeutics.
LABELING OF NATURAL PRODUCTS THROUGH DE NOVO
BIOSYNTHESIS
The coexistence of diffusible precursors and final products with
the same chemical handle introduces significant background in
the PDB production system, making it incompatible with in situ
bioorthogonal chemical transformations. To overcome the limi-
tation of PDB for tagging natural products, our group recently
developed a de novo biosynthesis platform to label natural prod-
ucts with a terminal alkyne functionality without the feeding of
alkynoic precursors (Figure 2) (Zhu et al., 2015). Inspired by
the discovery of gene clusters for jamaicamides and carmabins,
which are terminal alkyne-bearing PK-NRP hybrids from marine
cyanobacteria, we first characterized the terminal alkyne biosyn-
thetic machinery consisting of JamABC, an acyl-ACP synthetase,
a membrane-bound desaturase, and an ACP, respectively. In par-
ticular, we reconstituted the activities of JamABC by in vitro
biochemical analysis and confirmed JamB to be the first terminal
acetylenase that functions in a microbial PKS-NRPS pathway to
install a terminal alkyne functionality. The biochemical character-
ization of JamABC resulted in a compelling sequence of chemical
steps for generating the hexynoic starter unit for jamaicamides:
5-hexenoic acid is activated with ATP and loaded onto JamC by
JamA, followed by the modification catalyzed by JamB before
the priming of the PKS. A portable tri-gene cassette containing
jamABC was thus identified that could be used to install the
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FIGURE 2 | Schematic of de novo biosynthesis of terminal alkyne-tagged natural products and its potential application for in situ quantification.
terminal alkyne functionality into various molecular scaffolds of
other natural products through biosynthetic pathway engineer-
ing. As a proof of concept, we first targeted the biosynthesis of
terminal alkyne-bearing PKs through starter unit engineering. A
type III PKS HsPKS1 was chosen to assemble polyketide scaffolds
due to its promiscuity in selecting starter units. The introduction
of JamABC as well as HsPKS1 into E. coli successfully resulted
in the generation and incorporation of the terminal alkyne into
PKs, confirming the function of jamABC in the model organism
E. coli and demonstrating the feasibility of de novo synthesizing
terminal alkyne-labeled natural products by starter unit engi-
neering. In addition, we explored extender unit engineering, an
alternative strategy for incorporating an alkynoic extender unit
into the molecular scaffolds of PKs. Taking the advantage of the
promiscuous AntD-AT and AntE from the antimycin biosyn-
thetic machinery mentioned above, we de novo biosynthesized
antimycin analogs tagged with a terminal alkyne functionality
using an engineered E. coli strain containing jamABC and the
minimal set of genes necessary for antimycin dilactone scaffold
assembly.
IS THERE A GENERAL WAY TO SYNTHESIZE TAGGED
PKs/NRPs?
It is often challenging to obtain tagged PKs/NRPs through total
organic synthesis because of their structural complexity and stere-
ochemical centers, or through semi-synthesis because of their
chemical lability and the limited supply. Even though chemists
could design feasible routes to synthesize a tagged natural prod-
uct, these routes are not likely to be generalizable to other
natural products because of the diversity found in the func-
tional group arrays and scaffold architectures of PKs/NRPs.
Alternatively, biosynthesis is a promising approach to tag the
majority of natural products, particularly PKs and NRPs, due
to the modularity and co-linearity of their biosynthetic machin-
ery. A tagged building monomer can be incorporated into the
molecular scaffold of targeted natural products using the native
or engineered promiscuous biosynthetic machinery of natural
products. Various pathway-engineering strategies can be gener-
alized to synthesize tagged PKs/NRPs based on the features of
the natural products of interest and the clickable precursors.
For example, an alkynoic precursor can be introduced to label
many natural product families, including but not limited to PKs,
PK-NRP hybrids, lipopeptides, and lipoglycopeptides, through
strategies such as starter unit, extender unit, and tailoring unit
engineering. Particularly, starter unit engineering can be general-
ized to label PKs and lipopeptides that naturally contain fatty acyl
starter units. Extender unit engineering requires a promiscuous
AT domain that is readily achievable through domain swap-
ping or site-directed mutagenesis, and can possibly lead to the
regiospecific introduction of an alkyne functionality into any PKs
and PK-NRP hybrids inside living cells. In addition, since acyla-
tion/lipidation is one of themost commonmodification reactions
in natural product biosynthesis, and the responsible transferases
typically have relaxed substrate specificities toward various acyl
donors, it is highly likely that a functionalized acyl chain can be
incorporated into natural product scaffolds in a general fashion
through promiscuous tailoring acyltransferases.
DOES NATURAL PRODUCT LABELING HAVE A BROADER
IMPACT BEYOND CURRENT KNOWN APPLICATIONS?
The limited examples of natural product labeling have been
focused on structural diversification of natural products for drug
screening and mode of action studies through identification of
protein targets and cellular localization. Indeed, broader applica-
tions of natural product labeling can be foreseen, ranging from
natural product discovery to biology and enzymology. Firstly, a
general approach to tag PKs, NRPs and PK-NRP hybrids with
chemical handles would greatly accelerate the purification pro-
cess: the tagged natural products can be enriched and isolated
using functionalized resins via bioorthogonal reactions. Secondly,
the tagged natural products can be easily visualized and traced,
providing a unique opportunity to assess the natural roles of nat-
ural products. This is an emerging research field as it is now being
realized that many natural products are molecules of adapta-
tion that are produced for specific physiological or social reasons
(O’Brien and Wright, 2011). Despite a long history of natural
product research, the natural roles of these compounds are only
just now beginning to be understood. Last but not the least, the
de novo biosynthesis of tagged natural products would permit
in situ detection and quantification of natural products in pro-
ducing cell cultures through coupling with fluorogenic probes
(Shieh et al., 2012, 2014) (Figure 2). This strategy would lead
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to a natural product-based, quantitative, and high-throughput
screening method, which can be leveraged to understand and
engineer the biosynthesis of natural products for overproduction
and diversification.
ACKNOWLEDGMENTS
Research in our laboratory on this topic has been financially sup-
ported by the Pew Scholars Program and University of California
Cancer Research Coordinating Committee funds.
REFERENCES
Butler, M. S. (2008). Natural products to drugs: natural product-derived com-
pounds in clinical trials. Nat. Prod. Rep. 25, 475–516. doi: 10.1039/b514294f
Carlson, E. E. (2010). Natural products as chemical probes. ACS Chem. Biol. 5,
639–653. doi: 10.1021/cb100105c
Clardy, J., and Walsh, C. (2004). Lessons from natural molecules. Nature 432,
829–837. doi: 10.1038/nature03194
DeGuire, S. M., Earl, D. C., Du, Y., Crews, B. A., Jacobs, A. T., Ustione, A.,
et al. (2015). Fluorescent probes of the apoptolidins and their utility in
cellular localization studies. Angew. Chem. Int. Ed Engl. 54, 961–964. doi:
10.1002/anie.201408906
Dupuis, S. N., Robertson, A. W., Veinot, T., Monro, S. M. A., Douglas, S. E.,
Syvitski, R. T., et al. (2012). Synthetic diversification of natural products: semi-
synthesis and evaluation of triazole jadomycins. Chem. Sci. 3, 1640–1644. doi:
10.1038/nchembio.1296
Evans, M. J., Saghatelian, A., Sorensen, E. J., and Cravatt, B. F. (2005). Target discov-
ery in small-molecule cell-based screens by in situ proteome reactivity profiling.
Nat. Biotech. 23, 1303–1307. doi: 10.1038/nbt1149
Fischbach, M. A., and Walsh, C. T. (2006). Assembly-line enzymology for polyke-
tide and nonribosomal Peptide antibiotics: logic, machinery, and mechanisms.
Chem. Rev. 106, 3468–3496. doi: 10.1021/cr0503097
Grammel, M., and Hang, H. C. (2013). Chemical reporters for biological discovery.
Nat. Chem. Biol. 9, 475–484. doi: 10.1038/nchembio.1296
Harvey, C. J. B., and Khosla, C. (2012). “Precursor-directed biosynthesis of polyke-
tide and nonribosomal peptide natural products,” in Modern Tools for the
Synthesis of Complex Bioactive Molecules, eds J. Cossy and S. Arseniyadis
(Hoboken, NJ: John Wiley & Sons, Inc.). doi: 10.1002/9781118342886.ch14
Harvey, C. J., Puglisi, J. D., Pande, V. S., Cane, D. E., and Khosla, C. (2012).
Precursor directed biosynthesis of an orthogonally functional erythromycin
analogue: selectivity in the ribosome macrolide binding pocket. J. Am. Chem.
Soc. 134, 12259–12265. doi: 10.1021/ja304682q
Hertweck, C. (2009). The biosynthetic logic of polyketide diversity. Angew. Chem.
Int. Ed Engl. 48, 4688–4716. doi: 10.1002/anie.200806121
Lin, H., and Walsh, C. T. (2004). A chemoenzymatic approach to glycopeptide
antibiotics. J. Am. Chem. Soc. 126, 13998–14003. doi: 10.1021/ja045147v
Newman, D. J., and Cragg, G. M. (2012). Natural products as sources of new
drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311–335. doi:
10.1021/np200906s
O’Brien, J., and Wright, G. D. (2011). An ecological perspective of micro-
bial secondary metabolism. Curr. Opin. Biotechnol. 22, 552–558. doi:
10.1016/j.copbio.2011.03.010
Prescher, J. A., and Bertozzi, C. R. (2005). Chemistry in living systems. Nat. Chem.
Biol. 1, 13–21. doi: 10.1038/nchembio0605-13
Sandy, M., Rui, Z., Gallagher, J., and Zhang, W. (2012). Enzymatic synthe-
sis of dilactone scaffold of antimycins. ACS Chem. Biol. 7, 1956–1961. doi:
10.1021/cb300416w
Sandy, M., Zhu, X., Rui, Z., and Zhang, W. (2013). Characterization of AntB, a
promiscuous acyltransferase involved in antimycin biosynthesis. Org. Lett. 15,
3396–3399. doi: 10.1021/ol4014365
Shieh, P., Hangauer, M. J., and Bertozzi, C. R. (2012). Fluorogenic azidofluo-
resceins for biological imaging. J. Am. Chem. Soc. 134, 17428–17431. doi:
10.1021/ja308203h
Shieh, P., Siegrist, M. S., Cullen, A. J., and Bertozzi, C. R. (2014). Imaging
bacterial peptidoglycan with near-infrared fluorogenic azide probes.
Proc. Natl. Acad. Sci. U.S.A. 111, 5456–5461. doi: 10.1073/pnas.13227
27111
Sletten, E. M., and Bertozzi, C. R. (2009). Bioorthogonal chemistry: fishing for
selectivity in a sea of functionality. Angew. Chem. Int. Ed Engl. 48, 6974–6998.
doi: 10.1002/anie.200900942
Staub, I., and Sieber, S. A. (2008). β-lactams as selective chemical probes for
the in vivo labeling of bacterial enzymes involved in cell wall biosynthesis,
antibiotic resistance, and virulence. J. Am. Chem. Soc. 130, 13400–13409. doi:
10.1021/ja803349j
Staub, I., and Sieber, S. A. (2009). β-lactam probes as selective chemical-
proteomic tools for the identification and functional characterization of resis-
tance associated enzymes in MRSA. J. Am. Chem. Soc. 131, 6271–6276. doi:
10.1021/ja901304n
Sundermann, U., Bravo-Rodriguez, K., Klopries, S., Kushnir, S., Gomez, H.,
Sanchez-Garcia, E., et al. (2012). Enzyme-directed mutasynthesis: a combined
experimental and theoretical approach to substrate recognition of a polyketide
synthase. ACS Chem. Biol. 8, 443–450. doi: 10.1021/cb300505w
Thirumurugan, P., Matosiuk, D., and Jozwiak, K. (2013). Click
chemistry for drug development and diverse chemical-biology
applications. Chem. Rev. 113, 4905–4979. doi: 10.1021/cr20
0409f
Yan, Y., Chen, J., Zhang, L., Zheng, Q., Han, Y., Zhang, H., et al.
(2013). Multiplexing of combinatorial chemistry in antimycin
biosynthesis: expansion of molecular diversity and utility. Angew.
Chem. Int. Ed Engl. 52, 12308–12312. doi: 10.1002/anie.2013
05569
Yan, Y., Zhang, L., Ito, T., Qu, X., Asakawa, Y., Awakawa, T., et al. (2012).
Biosynthetic pathway for high structural diversity of a common dilactone core
in antimycin production. Org. Lett. 14, 4142–4145. doi: 10.1021/ol301785x
Zhu, X., Liu, J., and Zhang, W. (2015). De novo biosynthesis of termi-
nal alkyne-labeled natural products. Nat. Chem. Biol. 11, 115–120. doi:
10.1038/nchembio.1718
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 02 December 2014; accepted: 05 February 2015; published online: 20
February 2015.
Citation: Zhu X and Zhang W (2015) Tagging polyketides/non-ribosomal peptides
with a clickable functionality and applications. Front. Chem. 3:11. doi: 10.3389/fchem.
2015.00011
This article was submitted to Chemical Biology, a section of the journal Frontiers in
Chemistry.
Copyright © 2015 Zhu and Zhang. This is an open-access article distributed under
the terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) or
licensor are credited and that the original publication in this journal is cited, in
accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
www.frontiersin.org February 2015 | Volume 3 | Article 11 | 5
